LAVA Medtech Acquisition Corp.

Overview

• IndustryBlank Checks¹
• HeadquartersWaltham, Massachusetts¹
• Incorporated inDE³
• Business address303 Wyman St Ste 300, Waltham, Ma 02451³
• Filer category, Emerging growth company³

See how the biggest companies compare on our leaderboards

Corporate structure

LAVA Medtech Acquisition Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Who has led LAVA Medtech Acquisition Corp., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerAnthony Natale Oct 26, 2021 to Oct 26, 2021⁷
• PresidentGerald A. Brunk Oct 26, 2021 to Oct 26, 2021⁸
• Chief financial officerVasco Larcina Oct 26, 2021 to Oct 26, 2021⁹

Timeline

1. May 10, 20238-K Other events¹³
2. May 1, 20238-K Shareholder vote; Other events¹⁴
3. Apr 18, 20238-K Other events¹⁵
4. Dec 16, 20218-K Other events¹⁶
5. Nov 4, 20218-K Unregistered sale of shares; Other events¹⁷
6. Nov 1, 20218-K Entered a material agreement; Unregistered sale of shares; Executive or director change¹⁸
7. Oct 26, 2021New chief executive Anthony Natale becomes CEO⁷

Filings

45 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 6 major events, 8 insider forms, 11 large holders, 14 other. The latest 20:

1. Feb 9, 2024SC 13G/A EDGAR
2. Jan 10, 2024SC 13G/A AMENDMENT NO. 2 EDGAR
3. May 15, 202315-12G EDGAR
4. May 10, 20238-K CURRENT REPORT EDGAR
5. May 1, 20238-K CURRENT REPORT EDGAR
6. Apr 18, 20238-K CURRENT REPORT EDGAR
7. Apr 10, 2023DEF 14A EDGAR
8. Mar 30, 202310-K ANNUAL REPORT EDGAR
9. Mar 27, 2023PRE 14A EDGAR
10. Feb 14, 2023SC 13G EDGAR
11. Feb 13, 2023SC 13G/A AMENDMENT NO. 1 EDGAR
12. Feb 13, 2023SC 13G EDGAR
13. Nov 14, 202210-Q QUARTERLY REPORT EDGAR
14. Aug 15, 202210-Q QUARTERLY REPORT EDGAR
15. May 16, 202210-Q QUARTERLY REPORT EDGAR
16. May 13, 2022SC 13G EDGAR
17. Apr 5, 202210-K ANNUAL REPORT EDGAR
18. Apr 1, 2022NT 10-K NOTIFICATION OF LATE FILING EDGAR
19. Feb 14, 2022SC 13G SCHEDULE 13G EDGAR
20. Feb 11, 2022SC 13G EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Saba Capital Management, L.P.SC 13G/A, 2 filings May 13, 2022 to Feb 9, 2024¹⁹
• Castle Creek Arbitrage, LLCSC 13G/A, 3 filings Feb 11, 2022 to Jan 10, 2024²⁰
• Shaolin Capital Management LLCSC 13G, 1 filing Feb 14, 2023²¹
• PERISCOPE CAPITAL INC.SC 13G, 1 filing Feb 13, 2023²²
• LAVA Medtech Sponsor LPSC 13G, 1 filing Feb 14, 2022²³
• Beryl Capital Management LLCSC 13G/A, 2 filings Nov 8, 2021 to Feb 11, 2022²⁴
• Polar Asset Management Partners Inc.SC 13G, 1 filing Feb 9, 2022²⁵

SEC filer profile

How LAVA Medtech Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARLAVA Medtech Acquisition Corp.¹
• CIK0001855450
• Employer ID (EIN)86-2973712¹
• Filer status<br>emerging growth company¹
• Incorporated inDelaware¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)6770 Blank Checks¹
• SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance¹
• Business address303 Wyman St Ste 300, Waltham, MA 02451¹
• Phone416.213.4223¹
• Public float$114.5M as of Jun 30, 2022²
• On EDGAR sinceApr 29, 2021¹
• Filings48 in all: 3 (8), SC 13G (7), 8-K (6), 10-Q (4), SC 13G/A (4), CORRESP (3), 10-K (2), 15-12G (1)¹
  All 21 form types

  25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), DEF 14A (1), DRS (1), DRS/A (1), EFFECT (1), NT 10-K (1), PRE 14A (1), S-1 (1), S-1/A (1), UPLOAD (1)

• Latest filingsAnnual report (10-K) Mar 30, 2023
  Quarterly report (10-Q) Nov 14, 2022
  Proxy statement (DEF 14A) Apr 10, 2023
  Latest 8-K (8-K) May 10, 2023